Infectious Diseases
Biology 2026EL: Introduction to Microbiology
Fall 2025
A Brief Introduction to Infectious Disease
December 03
I. Introduction to Infectious Diseases
1. Definition and Scope
What Are Infectious Diseases?
Infectious diseases are illnesses caused by pathogenic microorganisms, including:
Bacteria
Viruses
Fungi
Parasites
Modes of Transmission:
Directly or indirectly from person to person
From animals to humans (zoonoses)
Through environmental reservoirs
Examples of Infectious Diseases:
Bacterial Infections:
Tuberculosis (TB)
Cholera
Viral Infections:
Influenza
COVID-19
Fungal Infections:
Candidiasis
Aspergillosis
Parasitic Infections:
Malaria
Giardiasis
Manifestation of Infectious Diseases:
Acute (short-term)
Chronic (long-lasting)
Latent (dormant with potential for reactivation)
2. Importance in Medicine and Public Health
Medical Relevance:
Infectious diseases create a significant burden on global healthcare.
Advances in diagnostics, antimicrobial therapy, and vaccines have improved survival rates.
However, challenges such as drug resistance and emerging pathogens remain.
Public Health Perspective:
Infectious diseases are linked to societal well-being and economic stability.
Outbreaks, pandemics, and endemic diseases necessitate coordinated public health responses to mitigate morbidity and mortality.
3. Historical Perspective
Understanding Historical Milestones:
Key milestones provide insight into the impact of infectious diseases on microbiology and medicine.
Key Milestones:
The Plague (Black Death, 14th Century):
Causative Agent: Yersinia pestis, transmitted by fleas.
Impact: Devastated Europe, killing an estimated 25-30 million people (30-50% of the population).
Public Health Measure: Highlighted the necessity for measures like quarantine.
Smallpox Eradication (1979):
Causative Agent: Variola virus, highly contagious and deadly.
Achievement: Global vaccination campaign led by WHO resulted in eradication, marking the first human disease eliminated worldwide.
4. COVID-19 Pandemic (2019–Present)
Causative Agent: SARS-CoV-2
Weighing Impact:
A modern example of a global health crisis with profound medical, social, and economic implications.
Accelerated mRNA vaccine development and renewed emphasis on pandemic preparedness.
5. Koch’s Postulates and Germ Theory of Disease
Germ Theory (19th Century):
Concept that microorganisms are causative agents of diseases; pioneered by Louis Pasteur, expanded by Robert Koch.
Koch’s Postulates: Criteria to link specific pathogens to specific diseases.
The microorganism must be found in all individuals suffering from the disease and absent from healthy ones.
The microorganism must be isolated and grown in pure culture.
The cultured organism must cause disease when introduced into a healthy host.
The microorganism must be re-isolated from the experimentally infected host.
Limitations: These postulates may not apply to viruses or diseases with multifactorial etiologies.
6. Current Global Impact
Epidemiology of Major Infectious Diseases:
Infectious diseases remain a leading cause of morbidity and mortality worldwide, particularly in low- and middle-income countries.
HIV/AIDS:
Over 38 million people globally live with HIV.
Ongoing challenges include access to antiretroviral therapy.
Tuberculosis (TB):
One of the top infectious killers; 10 million new cases and 1.6 million deaths in 2021.
Malaria:
Endemic in tropical regions; over 600,000 deaths annually, primarily affecting children under five.
COVID-19: Signified the critical role of global collaboration, rapid vaccine development, and strong healthcare infrastructure.
Antimicrobial Resistance (AMR):
A growing threat, with resistant bacteria projected to cause 10 million deaths annually by 2050 if not addressed.
7. Global Surveillance and Response Efforts
Strategies by Organizations:
Initiatives like the Global Health Security Agenda (GHSA) and organizations like WHO and CDC strive to strengthen disease surveillance, outbreak response, and public health interventions.
Technologies in genomics and AI enhance tracking and response capabilities to infectious disease threats.
II. Classification of Infectious Diseases
Purpose: Classifying infectious diseases allows structured understanding of diversity, pathogenesis, and modes of spread, facilitating diagnosis and management.
1. Based on Causative Agents
Classification primarily hinges on the microorganism type responsible for the disease. Each group has distinct characteristics in structure, replication, and clinical presentation.
Bacterial Diseases:
Caused by prokaryotic organisms (gram-positive, gram-negative, or atypical).
Examples:
Tuberculosis (Mycobacterium tuberculosis): Chronic pulmonary infection.
Streptococcal pharyngitis (Streptococcus pyogenes): Acute throat infection.
Antibiotic Resistance: Increasingly concerning, especially with pathogens like MRSA (Methicillin-resistant Staphylococcus aureus) and multidrug-resistant TB.
Viral Diseases:
Obligate intracellular pathogens relying on host cells for replication.
Examples:
Influenza (acute respiratory illness).
HIV/AIDS (chronic viral infection).
COVID-19 (SARS-CoV-2): The rapid global spread signifies emerging viruses.
Fungal Diseases:
Can cause superficial, subcutaneous, or systemic infections, particularly in immunocompromised individuals.
Examples:
Candidiasis (Candida albicans) often leads to oral thrush or vaginal infections.
Aspergillosis (Aspergillus species): Severe respiratory infection in immunosuppressed patients.
Parasitic Diseases:
Caused by protozoa or helminths, prevalent in tropical and subtropical regions.
Examples:
Malaria (Plasmodium species): Transmitted by Anopheles mosquitoes.
Schistosomiasis: Parasitic worms affecting urinary and intestinal tracts.
Prion Diseases:
Misfolded proteins inducing similar misfolding in normal proteins, leading to neurodegenerative disorders.
Examples:
Creutzfeldt-Jakob Disease (CJD): Rare and fatal brain disorder.
Bovine Spongiform Encephalopathy (BSE): Transmissible to humans as variant CJD.
2. By Transmission Mode
Modes of Transmission: Mechanisms by which infectious agents spread between hosts or environments.
Direct Transmission:
Pathogens transferred directly from person to person, e.g., respiratory droplets in influenza, sexual contact in STIs, physical contact.
Vertical Transmission:
From mother to fetus; examples include rubella and congenital syphilis.
Indirect Transmission:
Involves intermediaries (vehicles or vectors).
Vector-borne Transmission:
Pathogens transmitted by living organisms (e.g., mosquitoes for malaria).
Fomite Transmission:
Inanimate objects harboring pathogens (e.g., sharing needles for hepatitis B).
Waterborne and Foodborne Transmission:
Contaminated water or food as vehicles (e.g., cholera, salmonellosis).
3. Based on Severity and Duration
Categories:
Acute Infections:
Rapid onset and short duration; often self-limiting or treatable.
Examples:
Common cold (Rhinovirus).
Gastroenteritis (Escherichia coli).
Meningococcal meningitis.
Chronic Infections:
Long-term infections with persistent pathogens, causing prolonged symptoms.
Examples:
Hepatitis B and C.
TB (chronic).
HIV/AIDS (lifelong infection).
Latent Infections:
Pathogens remain dormant; reactivation possible.
Examples:
Herpes simplex virus (cold sores).
Varicella-zoster virus (shingles).
Latent tuberculosis reactivation.
III. Pathogenesis of Infectious Diseases
Definition: Pathogenesis refers to biological mechanisms by which infectious agents cause diseases in hosts. Understanding these mechanisms is essential for diagnosis, prevention, and treatment.
1. Mechanisms of Infection
Entry:
Pathogens access hosts through specific portals associated with infections.
Examples of Entry Portals:
Skin:
Pathogens can enter through cuts or vector bites (e.g., Plasmodium via mosquito).
Example: Staphylococcus aureus causing skin infections.
Respiratory Tract:
Inhalation of droplets/aerosols (e.g., Mycobacterium tuberculosis).
Gastrointestinal (GI) Tract:
Ingestion of contaminated food/water (e.g., Vibrio cholerae).
Urogenital Tract:
Entry through sexual contact (e.g., Neisseria gonorrhoeae).
Bloodstream:
Direct inoculation (e.g., Hepatitis B virus).
Colonization and Adherence:
Pathogens must attach to host cells; involves interactions between microbial adhesins and host receptors.
Example: Escherichia coli using pili for urinary tract adherence.
Invasion and Dissemination:
Pathogens penetrate tissues and spread, often through enzymes.
Enzymes Aiding Invasion:
Hyaluronidase: Breaks down hyaluronic acid in connective tissue.
Collagenase: Degrades collagen in host tissues.
Example: Clostridium perfringens producing enzymes facilitating rapid tissue destruction.
2. Host-Pathogen Interactions
Outcome of Infection: Influenced by immune defenses and pathogen virulence factors.
Virulence Factors: Molecules enhancing the pathogen's ability to infect and survive.
Toxins:
Exotoxins: Secreted proteins causing specific damage.
Example: Botulinum toxin from Clostridium botulinum causing paralysis.
Endotoxins: Lipopolysaccharides (LPS) from gram-negative bacteria triggering inflammation.
Example: Septic shock due to Escherichia coli.
Enzymes:
Example: Coagulase by Staphylococcus aureus forms protective clots around bacteria.
Immune Evasion Strategies:
Pathogens use strategies to avoid host immune systems.
Capsules: Prevent phagocytosis (e.g., Streptococcus pneumoniae).
Antigenic Variation: Changes in surface antigens modify immune detection.
Example: Trypanosoma brucei causing African sleeping sickness.
Intracellular Survival: Pathogens avoiding detection by growing inside host cells.
Example: Listeria monocytogenes grows intracellularly.
3. Clinical Manifestations
Outcomes of Interactions: The combination of virulence factors and immune responses lead to clinical signs and symptoms.
Fever:
A hallmark of infections, triggered by pyrogens released in response to microbial products.
Example: Fever in typhoid fever (Salmonella typhi).
Inflammation:
Innate immune response characterized by redness, swelling, heat, and pain in infections.
Example: Cellulitis from Staphylococcus aureus.
Organ-Specific Symptoms:
Targeted symptoms based on infected organs;
Respiratory Infections: Cough, shortness of breath (e.g., pneumonia).
GI Infections: Diarrhea, abdominal pain (e.g., cholera).
Neurological Infections: Headache, stiff neck (e.g., meningitis).
IV. Modes of Disease Transmission and Epidemiology
Focus: How infectious diseases spread and the epidemiological principles for controlling outbreaks. Understanding transmission dynamics aids public health strategies.
1. Transmission Dynamics
Chain of Infection:
Components that outline how diseases spread:
Reservoir: Natural habitat for pathogens.
Examples:
Humans (e.g., Mycobacterium tuberculosis for TB).
Animals (Plasmodium spp. in mosquitoes for malaria).
Environmental (soil for Clostridium tetani).
Mode of Exit: Pathogen departure from reservoir.
Examples: Respiratory droplets (COVID-19), feces (cholera).
Mode of Transmission: Means pathogens reach hosts.
Includes: Direct, indirect, airborne, droplet, vector-borne.
Mode of Entry: Route of pathogen entry to hosts.
Examples: Skin breaches (tetanus), mucosal surfaces (HIV).
Susceptible Host: Individuals lacking immunity.
Risk Factors: Age, chronic illness, malnutrition, immunosuppression.
Role of Carriers and Reservoirs:
Carriers: Infected individuals who transmit pathogens without symptoms.
Example: Typhoid Mary (asymptomatic carrier of Salmonella typhi).
Reservoirs: Critical for disease persistence and re-emergence.
Example: Bats as reservoirs for zoonotic viruses (e.g., Ebola, coronaviruses).
2. Epidemiological Concepts
Purpose: To measure, predict, and control disease spread.
Incidence:
Number of new disease cases in a specific time period/population.
Example: COVID-19 incidence surged globally during early pandemic waves.
Prevalence:
Total number of cases (new and existing) at a given time/population.
Example: High prevalence of HIV due to its chronic nature.
Basic Reproductive Number (R₀):
Average number of secondary infections from one infected individual.
If R₀ > 1: infection spreads; If R₀ < 1: declines.
Examples: COVID-19 (~2-3), Measles (12-18).
3. Case Studies: Airborne vs. Vector-Borne Diseases
Airborne Disease: Influenza
Transmission: Via respiratory droplets/aerosols from coughs/sneezes/talks.
Epidemiology: Seasonal outbreaks; annual incidence variations due to mutations (antigenic drift).
Control Measures: Vaccinations reduce population susceptibility. Personal protective equipment and social distancing are vital.
Impact: Influenza pandemics (e.g., Spanish flu in 1918) resulted in significant mortality.
Vector-Borne Disease: Malaria
Transmission: Bites from infected Anopheles mosquitoes.
Epidemiology: Predominantly in tropical/subtropical regions.
Influenced by climate, vector control, healthcare access.
Control Measures: ITNs, IRS, prophylactic drugs for travelers, vaccine developments aim to reduce burden.
Impact: remains a leading cause of morbidity/mortality; ~247 million cases in 2021.
V. Diagnosis and Treatment of Infectious Diseases
Importance: Accurate diagnosis and treatment are critical for managing infectious diseases.
1. Diagnostic Methods
Microbiological Techniques: These remain the foundation of diagnostic microbiology.
Culture:
Growing pathogens in specific media for identification and susceptibility testing.
Strengths: Provides live organisms for additional analysis.
Limitations: Time-consuming (Mycobacterium tuberculosis cultures take weeks).
Example: Blood cultures for detecting bacterial infections (e.g., septicemia).
Microscopy:
Observing pathogens using staining techniques.
Gram Staining: Differentiates gram-positive from gram-negative.
Example: Staphylococcus aureus (gram-positive) vs. Escherichia coli (gram-negative).
Acid-Fast Staining: Identifies mycobacteria (e.g., M. tuberculosis).
Strengths: Rapid preliminary identification.
Limitations: May miss pathogens in low concentrations.
Molecular Diagnostics: Advanced methods targeting genetic material or proteins of specific pathogens.
Polymerase Chain Reaction (PCR):
Detects pathogen DNA or RNA with high sensitivity and specificity.
Example: Detecting SARS-CoV-2 in respiratory samples.
Strengths: Rapid and reliable, even for difficult-to-culture pathogens.
Limitations: Expensive, needs specialized equipment.
Antigen/Antibody Tests:
Antigen tests identify pathogen-specific proteins; example: rapid tests for COVID-19.
Antibody tests show immune responses; example: current or past infections.
Strengths: Easy to use/interpret.
Limitations: Antibody tests may not distinguish active from resolved infections.
2. Treatment Modalities
Purpose: Eliminate pathogens, manage symptoms, prevent complications/transmission.
Antimicrobials: Target specific pathogen types.
Antibiotics:
Treat bacterial infections by inhibiting essential processes (e.g., cell wall synthesis, protein synthesis, DNA replication).
Challenges:
Resistance due to misuse and overuse; examples include MRSA.
Side Effects: Allergic reactions, disruption of gut microbiota (e.g., Clostridioides difficile infections).
Antivirals:
Inhibit viral replication or function; examples include acyclovir for herpes, oseltamivir for influenza.
Limitations: Limited options for many viruses, rapid mutations.
Antifungals:
Target fungal cells; examples include amphotericin B (broad-spectrum) and azoles like fluconazole for candidiasis.
Antiparasitics: Treat protozoal/helminthic infections; examples include artemisinin-based therapies for malaria and albendazole.
3. Emerging Therapies
Vaccines:
Purpose: Prevent infections via induced immunity.
Examples: mRNA vaccines (e.g., Pfizer-BioNTech COVID-19), live-attenuated vaccines (MMR).
Importance: Results in disease eradication (e.g., smallpox), significant morbidity reduction.
Challenges: Vaccine hesitancy, logistical barriers in low-income areas.
Immunotherapy:
Enhances the host immune system against infections; examples include interferons for hepatitis C.
Monoclonal Antibodies:
Target specific pathogens; examples include monoclonal antibodies against RSV and Regeneron’s cocktail for COVID-19.
Benefits: High specificity and efficacy.
Limitations: Expensive, precise production required.
VI. Emerging and Re-emerging Infectious Diseases
Importance: Emerging and re-emerging infections present global health challenges due to interactions among environmental, societal, and biological factors.
1. Drivers of Disease Emergence
Urbanization:
Rapid growth and poor sanitation increase pathogen transmission; urban slums as cholera and tuberculosis hotspots.
Global travel facilitates rapid disease spread (e.g., COVID-19).
Climate Change:
Altered ecosystems affect vector distribution (e.g., dengue, chikungunya).
Natural disasters disrupt healthcare and promote waterborne diseases.
Antibiotic Misuse:
Overuse accelerates drug resistance; examples include inappropriate prescriptions leading to resistant strains in hospitals and livestock.
2. Case Studies
Zoonotic Diseases:
Ebola Virus:
Likely transmitted from bats; human-to-human spread via fluids.
Impact: 28,000 cases and 11,000 deaths (2014–2016 West Africa outbreak), challenges in healthcare capacity.
COVID-19 (SARS-CoV-2):
Originated likely from wildlife trade in 2019; significant global deaths and economic disruption.
Lessons Learned: Need for robust systems and global solidarity.
Drug-Resistant Pathogens:
MRSA:
Emerged from widespread antibiotic use, causing severe infections with limited treatment options.
XDR-TB:
Resistant to major drugs, complicating expensive treatment regimens; drivers include poor adherence and insufficient public health systems.
3. Global Response
World Health Organization (WHO):
Central role in disease surveillance and outbreak response; capacity-building efforts.
Initiatives:
International Health Regulations (IHR): improves global health security.
Pandemic Influenza Preparedness (PIP) framework tools development.
The One Health Approach: Recognizes interconnectedness of health across humans, animals, and the environment.
Key strategies include zoonotic disease surveillance, managing antibiotic resistance, and mitigating climate change risks.
VII. Prevention and Control of Infectious Diseases
Importance: Effectively reducing diseases requires comprehensive public health approaches and behavioral changes.
1. Public Health Measures
Vaccination Programs:
One of the most effective prevention tools; examples include eradication of smallpox and reduction of polio, measles, and influenza cases.
Mechanism: Vaccines stimulate immunity without causing diseases; challenges include maintaining high coverage and combating hesitancy.
Sanitation and Clean Water Access:
Improved hygiene substantially decreases waterborne and fecal-oral infections (e.g., cholera, typhoid).
Strategies: handwashing campaigns, sanitation infrastructure in resource-limited settings.
Quarantine and Isolation:
Restrictions on infected individuals’ movements prevent disease spread (e.g., COVID-19).
Limitations: Ethical dilemmas and economic consequences.
2. Behavioral Interventions
Hygiene Practices:
Regular handwashing and cough etiquette reduce transmission risk.
Safe Sex Practices:
Promoting condom use and regular STI testing helps manage diseases like HIV/AIDS.
Responsible Antibiotic Use:
Addressing overprescription through awareness campaigns and education for healthcare providers.
3. Global Challenges
Vaccine Hesitancy:
Fueled by misinformation and distrust; examples include measles outbreaks in high-income areas.
Solutions: Transparent communication and community engagement through trusted local figures.
Resource-Limited Settings:
Infrastructure lacked in low-income countries hampers disease prevention.
Strategies: Strengthening healthcare systems through international partnerships, implementing cost-effective procedures.
VIII. Summary
Key Recap:
Microbiology is essential in understanding and combating infectious diseases—from pathogen identification to development of therapies.
Knowledge of pathogen interactions with hosts and their transmission dynamics aids effective response strategies.
Public Health and Behavioral Interventions: Integrating strategies effectively reduces global infection burdens, while addressing behavioral challenges mitigates transmission.
Conclusion: Microbiology signifies a key component in addressing infectious disease threats, emphasizing research, evidence-based practices, and solving logistical challenges for future public health resilience.